Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Evogene
EVGNCurrent price
2.24 USD
+0.07 USD (+3.23%)
Last closed
2.28 USD
Company
www.evogene.com
ISIN
IL0011050551
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
14 166 697 USD
Yield for 12 month
-61.38 %
1Y
3Y
5Y
10Y
15Y
EVGN
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health, agriculture, and other industrial applications through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, gastrointestinal inflammatory related disorders, and antimicrobial resistance organisms. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel. Address: 13 Gad Feinstein Street, Rehovot, Israel, 7638517
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
13.5 USDP/E ratio
–Dividend Yield
–Current Year
+5 640 000 USD
Last Year
+1 675 000 USD
Current Quarter
+914 000 USD
Last Quarter
+4 190 000 USD
Current Year
+1 399 000 USD
Last Year
+766 000 USD
Current Quarter
-236 000 USD
Last Quarter
+3 880 000 USD
Key Figures EVGN
1 year
3 years
5 years
10 years
EBITDA
-19 672 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-28.46 %
PEG Ratio
–
Return On Equity TTM
-82.37 %
Wall Street Target Price
13.5 USD
Revenue TTM
9 449 000 USD
Book Value
0.6 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
39.8 %
Dividend Yield
–
Gross Profit TTM
766 000 USD
Earnings per share
-3.84 USD
Diluted Eps TTM
-3.84 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-210.26 %
Dividend Analytics EVGN
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History EVGN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:10
Payout Ratio
–
Last Split Date
25.07.2024
Dividend Date
–
Stock Valuation EVGN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
0.462
Price Sales TTM
1.4993
Enterprise Value EBITDA
-0.8129
Price Book MRQ
4.3035
Financials EVGN
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators EVGN
For 52 weeks
2.14 USD
10.4 USD
50 Day MA
2.95 USD
Shares Short Prior Month
14 621
200 Day MA
6.05 USD
Short Ratio
1
Shares Short
26 791
Short Percent
0.5 %
BeatStart